Synthesis and cardioprotective effectiveness of arginine succinates
https://doi.org/10.29235/1561-8331-2020-56-2-181-186
Abstract
The synthesis was developed and physic-chemical properties of the pharmaceutical substance the di-L-arginine succinate were determined. Its cardioprotective effectiveness in cases of ischemic-reperfusion injury of the myocardium was demonstrated in experiments on rats. The substance was used to obtain the drug Inokardin of cardioprotective action.
About the Authors
D. V. Lopatik
Institute of Physical Organic Chemistry of the National Academy of Sciences of Belarus
Belarus
Belarus
Dina V. Lopatik – Ph. D. (Chemistry), Senior Researcher
13, Surganov Str., 220072, Minsk
Z. I. Kuvaeva
Institute of Physical Organic Chemistry of the National Academy of Sciences of Belarus
Belarus
Belarus
Zoya I. Kuvaeva – D. Sc. (Chemistry), Professor, Head of the Department
13, Surganov Str., 220072, Minsk
O. M. Bondareva
Institute of Physical Organic Chemistry of the National Academy of Sciences of Belarus
Belarus
Belarus
Olga M. Bondareva – Researcher
13, Surganov Str., 220072, Minsk
References
1. Atkins R. Vita-Nutrient Solution: Nature’s Answers to Drugs. Мoscow, Ripol Classic Publ., 2000, pp. 183–186 (in Russian).
2. Wu G., Mtininger C. J. Arginine Nutriation and Cardiovascular Function. Journal of Nutrition, 2000, vol. 130, pp. 2626–2629. https://doi.org/10.1093/jn/130.11.2626
3. Dubovik B. V., Zhdanov A. A., Romanovskii D. I. Comparative efficacy of L-arginine hydrochloride and L-arginine succinate in reducing myocardial ischemia-reperfusion injury in rats. Meditsinskii zhurnal = Medical Journal, 2005, vol. 4, no. 14, pp. 51–53 (in Russian).
4. Katerinchuk I. P. Cardiac effects of arginine and the effectiveness of cardioarginine in cardiovascular disease. Zdorov′ya Ukraїni [Health of Ukraine], 2012, no. 9, pp. 76 (in Russian).
5. Gorchakova N. A., Bezrukov V. V., Chekman І. S., Kuprash L. P., Sikalo N. V. Pharmaceutical product of cardiological action. Patent no. 66456 Ukraine. Publ. date 17.05. 2004 (in Ukrainian).
6. Kovalenko А. А., Belaykov N. V. Succinic acid: pharmacological activity and dosage forms. Farmaciya = Pharmacy, 2000, vol. 49, no. 5, pp. 40–43 (in Russian).
7. Richard V., Henry J.-P., Thuillez Ch. Is Guanidine Succinate a Precursor for Nitric Oxide Synthesis in Rat Vascular Tissue? Journal of Cardiovascular Pharmacology, 1994, vol. 24, pp. 50–54. https://doi.org/10.1097/00005344-199407000-00009
8. Grabar N. Cardioarginine-Health – a new original development of the OOO “Health” pharmaceutical company. Mistetstvo lіkuvannya = Art of Treatment, 2011, vol. 80, no. 4, pp. 66 (in Russian).
9. Kovalenko A. L., Petrov A. Yu. Balanced infusion solution: Patent RU no. 2549448. Publ. date 27.04.2015 (in Russian).
10. Vasil’ev A. G., Trashkov A. P., Kovalenko A. L., Verlov N. A., Petrov A. Yu., Valeev V. V. Assessment of Specific Pharmacologic Activity of Unifusol on Endothelium Dysfunction Model Induced by N-Nitro-L-Arginine Methyl Ether. Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology, 2016, vol. 79, no. 11, pp. 11–14 (in Russian).
11. Valeev V. V., Trashkov A. P., Kovalenko A. L., Petrov A. U., Vasiliev A. G. Sodium-L-arginine succinate – a new vasodilating medicine for the treatment and prophylaxis of doxorubicin-induced cardiotoxicity. Patologicheskaya fiziologiya i eksperimental’naya terapiya = Pathological physiology and experimental therapy, 2016, vol. 60, no. 4, pp. 52–57 (in Russian).
12. Stel’makh V. V., Kovalenko A. L., Ketlinskaya O. S., Kharitonova T. V., Drogomiretskaya E. I. New Sodium-L-Arginine Succinate Vasodilator: Phase-I Investigation Results. Russian Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology, 2018, vol. 81, no. 10, pp. 8–14 (in Russian).
13. Lopatik D. V., Kuvaeva Z. I., Bondareva O. M., Mikhalevskaya S. V., Ryabikova V. V., Moroz I. N. New chemical products based on amino acids. Tez. dokl. na XXIII Mezhdunar. nauch.-tekhn. konf. «Reaktiv-2010» [Proc. of the XXIII International scientific and technical conf. “Reagent 2010”]. Minsk, 2010, pp. 30 (in Russian).
14. Pharmaceutical products of domestic pharmaceutical manufacturers. Guaranteed Belarusian quality. Minsk, 2016, pp. 47 (in Russian).
15. Litvinova T. I., Luchko V. S., Petelsky Yu. V., Anatsko S. V., Shirma Yu. V., Makhomet E. V. Application of the drug Inocardine in the complex treatment of patients with coronary heart disease. Tez. dokl. Vseros. nauch.-prakt. konf. «Kardiologiya–2017» [Proc. All-Rus. Scientific-practical conf. “Cardiology 2017”]. Moscow, InterMedservice Publ., 2017, pp. 50–51 (in Russian).
Review
Views: 1056
Email this article 